Although the incidence of intraventricular hemorrhage (IVH) and posthemorrhagic hydrocephalus (PHH) in preterm infants is decreasing, these conditions are still associated with poor neurodevelopmental and functional outcomes. Additionally, with the growing viability of infants born at younger estimated gestational ages (EGAs), these conditions remain significant burdens as IVH severity increases with prematurity. Despite improvements in neonatal care, there still lacks a uniform paradigm for the treatment and management of PHH. Patients with PHH typically are initially treated with a temporizing device that allows for these infants to develop more favorable immunologic and nutritional statuses; a permanent ventriculoperitoneal (VP) shunt is later inserted in cases of persistent ventricular dilation and symptomatic hydrocephalus. This patient population is at high risk for temporizing device and shunt complications, especially shunt obstruction and infection, slit-ventricle syndrome, and the development of loculated hydrocephalus. The impact of these complications on long-term neurodevelopmental outcomes is unclear; however, there are few alternative methods to avoid prolonged shunt dependence in these patients.
|Original language||English (US)|
|Title of host publication||Complications of CSF Shunting in Hydrocephalus|
|Subtitle of host publication||Prevention, Identification, and Management|
|Publisher||Springer International Publishing|
|Number of pages||10|
|State||Published - Jan 1 2015|
ASJC Scopus subject areas